The association between event-free survival and pathological complete response to neoadjuvant lapatinib, trastuzumab or their combination in HER2-positive breast cancer. Survival follow-up analysis of the NeoALTTO study (BIG 1-06) Meeting Abstract


Authors: Piccart-Gebhart, M.; Holmes, A. P.; de Azambuja, E.; Di Cosimo, S.; Swaby, R.; Untch, M.; Jackisch, C.; Lang, I.; Smith, I.; Boyle, F.; Xu, B.; Barrios, C.; Gelber, R.; Eidtmann, H.; Baselga, J.
Abstract Title: The association between event-free survival and pathological complete response to neoadjuvant lapatinib, trastuzumab or their combination in HER2-positive breast cancer. Survival follow-up analysis of the NeoALTTO study (BIG 1-06)
Meeting Title: 36th Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS)
Journal Title: Cancer Research
Volume: 73
Issue: 24 Suppl.
Meeting Dates: 2013 Dec 10-14
Meeting Location: San Antonio, TX
ISSN: 0008-5472
Publisher: American Association for Cancer Research  
Date Published: 2013-12-15
Language: English
ACCESSION: WOS:000209496903100
DOI: 10.1158/0008-5472.sabcs13-s1-01
PROVIDER: wos
Notes: Meeting Abstract: S1-01 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Jose T Baselga
    484 Baselga